(Q31034858)

15 August 2017

1 reference

title

Therapy of X-linked adrenoleukodystrophy (English)

1 reference

X-linked adrenoleukodystrophy

15 August 2017

1 reference

Hugo W Moser

1

1 reference

15 August 2017

1 April 2006

1 reference

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

2

1 reference

15 August 2017

246-253

1 reference

Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

The human ATP-binding cassette (ABC) transporter superfamily.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

X-linked adrenoleukodystrophy: genes, mutations, and phenotypes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Cognitive and brain magnetic resonance imaging findings in adrenomyeloneuropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenoleukodystrophy: a scoring method for brain MR observations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenoleukodystrophy: correlating MR imaging with CT.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Clinical Aspects of Adrenoleukodystrophy and Adrenomyeloneuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenoleukodystrophy: phenotypic variability and implications for therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Fatty acid abnormality in adrenoleukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy I. Clinical and endocrinologic aspects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenoleukodystrophy. A clinical and pathological study of 17 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy.

21 June 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Bronzekrankheit und sklerosierende Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Rett syndrome: a disorder affecting early brain growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Biochemical effect of intravenous arginine butyrate in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

X-linked adrenoleukodystrophy in patients with idiopathic addison disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURX.2006.01.004

Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3593437

Adrenoleukodystrophy: the most frequent genetic cause of Addison's disease

25 November 2018

1 reference

12 December 2020

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

1 reference

12 December 2020

Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening

1 reference

12 December 2020

Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy

1 reference

12 December 2020

Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study

1 reference

12 December 2020

Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients

1 reference

12 December 2020

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy

1 reference

12 December 2020

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening

1 reference

12 December 2020

Cerebral X-linked adrenoleukodystrophy in a girl with Xq27-Ter deletion

1 reference

12 December 2020

Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation

1 reference

12 December 2020

MR findings in adult-onset adrenoleukodystrophy

1 reference

12 December 2020

Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study

1 reference

12 December 2020

Immunoablation does not delay the neurologic progression of X-linked adrenoleukodystrophy

1 reference

12 December 2020

Prenatal diagnosis of X-linked adrenoleukodystrophy combining biochemical, immunocytochemical and DNA analyses

1 reference

12 December 2020

10.1016/J.NURX.2006.01.004

Identifiers

DOI

1 reference

15 August 2017

1 reference

PMC publication ID

3593437

15 August 2017

PubMed publication ID

16554262

1 reference

PMC publication ID

3593437